HomeDRUG • NASDAQ
add
Bright Minds Biosciences Inc
Previous close
$21.70
Day range
$34.00 - $79.02
Year range
$0.93 - $79.02
Market cap
458.53M CAD
Avg Volume
4.70M
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
In the news
Financials
Income Statement
Revenue
Net income
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | -246.10K | -117.20% |
Net income | 214.92K | 114.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.19M | -23.86% |
Total assets | 6.28M | -25.80% |
Total liabilities | 178.63K | -75.69% |
Total equity | 6.10M | — |
Shares outstanding | 4.46M | — |
Price to book | 15.84 | — |
Return on assets | 9.61% | — |
Return on capital | 10.40% | — |
Cash Flow
Net change in cash
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 214.92K | 114.74% |
Cash from operations | 240.16K | 114.55% |
Cash from investing | — | — |
Cash from financing | -21.96K | -2.18% |
Net change in cash | 257.81K | 116.72% |
Free cash flow | 127.56K | 111.76% |
About
Founded
2017
Website